VET vs CVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

VET

40.8
AI Score
VS
VET Wins

CVE

35.7
AI Score

Investment Advisor Scores

VET

41score
Recommendation
HOLD

CVE

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric VET CVE Winner
Forward P/E 15.1745 11.0254 CVE
PEG Ratio 3.58 0.45 CVE
Revenue Growth 23.1% 41.5% CVE
Earnings Growth -94.9% 239.1% CVE
Tradestie Score 40.8/100 35.7/100 VET
Profit Margin -24.2% 12.4% CVE
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY VET

Relative Price Performance (Last 90 Days)

VET 1M: -5.4% · 3M: +24.7% CVE 1M: -1.7% · 3M: +24.7%

Current Technical Phase

VET

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 39.3 · Price: $11.60

CVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.9 · Price: $30.93

Fundamentals Snapshot

Metric VET CVE
Market Cap — —
Forward P/E 10.7 11.8
Trailing P/E — 12.1
Revenue (TTM) — —
Revenue Growth 0.2% 0.4%
Gross Margin 0.6% 0.3%
Operating Margin 0.5% 0.2%
EPS -2.11 2.58
Dividend Yield 0.05% 0.03%

Frequently Asked Questions

Based on our detailed analysis, VET is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.